AzTrials
AzTrials

AmbulancesNCT03940443

Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS

An observational study of Ambulances and Traumatic Brain Injury, run by Dalarna County Council, Sweden at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Introduction: Patients suffering a time-critical medical condition require rapid prehospital assessment and treatment and most often quick transportation to definitive care. This can be decisive for patient outcome. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
2,000 participants
Where
1 siteSweden
Study dates
3 Sep 2019to 1 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients considered to be suffering a TBI or acute MI and been treated by either GEMS or HEMS.

Who may be able to join

  • Patients suffering from a time-critical condition:
  • Cardiac arrest
  • Acute myocardial infarction
  • Severe chest pain
  • Stroke
  • Severe respiratory difficulties
  • Severe trauma

Who cannot join

  • Patient in a non time-critical condition:
  • Minor trauma
  • Minor respiratory difficulties
  • Minor chest pain
  • Minor neurologic disorder

Trial locations and contacts

1 site in 1 country.

Anneli Strömsöe, PhD contact

+46 23 49 00 00

anneli.stromsoe@ltdalarna.se

Sweden1 site, 1 recruiting
  • Region Dalarna

    Falun, 791 82

    David Summermatter, RN, MSc, +46 72 249 55 40, david.summermatter@ltdalarna.se

    Anneli Strömsöe, PhD, +46 23 49 00 00, anneli.stromsoe@ltdalarna.se

    Recruiting

Other trials in Sweden

About this study

Official title: Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between Ground Emergency Medical Services and Helicopter Emergency Medical Services - a Descriptive and Comparative Study

Introduction: Patients suffering a time-critical medical condition require rapid prehospital assessment and treatment and most often quick transportation to definitive care. This can be decisive for patient outcome. In order to minimize time from assessment to treatment, thus lowering mortality and morbidity, it is important to have a well-coordinated chain of care. The efficient use of Ground Emergency Medical Services (GEMS) and Helicopter Emergency Medical Services (HEMS) is essential in such a chain of care.

Objectives: The aim is to describe differences in mortality, morbidity, assessment and treatment of two time-critical conditions, traumatic brain injury (TBI) and acute myocardial infarction (MI), in patients assessed by GEMS and HEMS respectively.

Read more

Method: The project consists of a descriptive observational study and comparative cohort study. Inclusion criteria are patients considered to be suffering from TBI and acute MI, which are treated by GEMS or HEMS in the regions of Uppsala, Jämtland/Härjedalen, Dalarna and Värmland.

Clinical significance: The results expect to be the basis for further studies aiming to optimize the utilization of GEMS and HEMS.

Read the detailed description

Background Efficient healthcare can be decisive for patients who suffer an out-of-hospital time-critical medical condition. If untreated these conditions can compromise health and even become life-threatening. The most common time-critical conditions assessed and treated in the prehospital environment are cardiac arrest, chest pain, stroke, severe respiratory difficulties and severe trauma. In addition to receiving rapid assessment and immediate treatment, it is also important that these patients are quickly transported to a location where they can receive the appropriate level of care.

If a person is suffering from an out-of-hospital time-critical medical condition, the emergency medical dispatch center is alerted when contacted by the use of '112' the emergency phone number common to European countries. An operator will answer the call and assess the situation using a medical criteria-based index . The operator will than dispatch the right resource, either Ground Emergency Medical Services (GEMS) or Helicopter Emergency Medical Services (HEMS).

The dispatching of HEMS has long been considered as a weak link in the chain of response. The use of HEMS is region specific and that the mechanism of injury is a poor predictor for HEMS dispatch. Dispatch criteria should be designed to match specific systems.

The prehospital care in Sweden has developed rapidly over recent decades. Prehospital care today is a system in which qualified prehospital care providers deliver advanced emergency healthcare. GEMS vehicles are staffed with at least one registered nurse (RN) and over the years programs has been developed, which leads to at postgraduate diploma in prehospital care nursing. GEMS has less access to medical-technical equipment for advanced medical life support and critical care. The HEMS medical staff consists of a RN with a postgraduate diploma in prehospital care nursing and a physician, specialized in anaesthesia and intensive care and HEMS is equipped for advanced life support and critical care interventions. All of Sweden´s Emergency Medical Services (EMS) organisations require educational programs and certification for prehospital trauma and emergency medical care on a yearly basis. These educational programs aim to improve emergency care based on evidence based medicine. Previous studies have demonstrated that EMS provides rapid access to the healthcare system, quality care on scene, and transport with support en-route to appropriate care if not provided on scene. An increased survival rate could be identified in trauma patients if transported by HEMS, compared to GEMS. Another study reported increased survival rate of patients over 55 years of age who suffered minor trauma and where transported by HEMS compared to GEMS. Previous studies has also shown an advantage in using HEMS in treating patients with acute MI, initiating treatment as early as possible. The time gained, using HEMS, in treating acute MI was reported to reduced mortality compared to patients treated by GEMS.

There is a steadily growing body of literature that describes the activities in both GEMS and HEMS and the assessment and treatment of Traumatic Brain Injury (TBI) and acute Myocardial Infarction (MI). But these studies are not generalisable to the Swedish prehospital environment, due to the importance of evaluating triage criteria for HEMS activation by local and regional authorities and the variation of health care system in which GEMS and HEMS operate. A systematic collection and analysis of incidence and outcomes in prehospital care of time-critical conditions can therefore increase dispatch accuracy and contribute to knowledge about which patients should be assessed and treated by GEMS and HEMS, respectively. This, in turn can lead to cost-effectiveness and better outcomes. Previous studies have been criticized for the low quality of evidence and variation in study methods, which overall has resulted in a lack of credibility in the conclusions of the studies.

TBI is a major cause of death, disability and cost to society. The perceived benefit of HEMS transport of trauma patients, including TBI is driven by the principle that time is a critical factor in the survival of severely injured patients. For patients with acute MI, time to treatment should be short as possible because every delay increases mortality. Since today, from a national perspective, both descriptive data and evidence in the form of studies comparing GEMS and HEMS are modest, it is very important to describe GEMS and HEMS for assessment, treatment and outcome of patients suffering from TBI and acute MI. Once a thorough description of GEMS and HEMS has been completed, hypothesis-generating controlled studies can be initiated. The project is expected to contribute to optimisation of the prehospital assessment and treatment of TBI and acute MI and the role of GEMS and HEMS in Sweden.

Overall aim To describe and to compare morbidity and mortality, assessment and treatment of TBI and acute MI in patients treated by GEMS and HEMS.

Specific aim Study I To describe the scope and characteristics of GEMS and HEMS assessing and treating patients with TBI and acute MI in the field of prehospital care and to illustrate the complexity of the topic. The collected data will be the starting point for study II.

Study II To understand the effects of GEMS compared to HEMS in patients suffering from TBI and acute MI and what care logistics should we use. Previous collected data from study I will be used for this purpose.

Research questions

Study I

  1. What is the incidence of mortality and morbidity in the assessment and treatment of TBI and acute MI of GEMS and HEMS?
  2. What types of assessment and treatment are performed in patients with TBI and acute MI?

Study II

  1. What are the field diagnosis accuracy related to final diagnosis? Are there differences in diagnose accuracy in patients treated and transported with GEMS vs. HEMS?
  2. What are the differences between GEMS vs. HEMS on mortality and morbidity in patients suffering from TBI and acute MI?

Hypothesis (study II): HEMS compared to GEMS provides significant time gains resulting in fewer morbidity and reduced mortality when assessing and treating patients with TBI and acute MI.

Design: Study I is a descriptive observation study with quantitative approach. Study II consists of a comparative cohort study with 30-day follow up. These studies will be reported according to STROBE´s recommendations for observational studies and cohort studies. The project will be registered in ClinicalTrials.gov before the start of the study.

Setting

Population:

Study I consists of patients considered to be suffering a TBI or acute MI and been treated by either GEMS or HEMS during the period of January 1st, 2018 to December 31st, 2018. Inclusion criteria are GEMS and HEMS prehospital care providers, men and women ≥18 years of age in a time-critical condition. Exclusion criteria are men and women < 18 years of age in a non-time-critical condition. Participating counties are located in the middle of Sweden.

Study II consists of patients considered to be suffering from a TBI or acute MI treated by GEMS prehospital care providers (Reference) (n=2000) and HEMS (Exposed) (n=2000) during the period of January 1st, 2017 to December 31st, 2018. Inclusion criteria are GEMS and HEMS prehospital care providers, men and women ≥18 years of age in a time-critical condition. Exclusion criteria are men and women < 18 years of age. Participating counties are located in the middle of Sweden.

Data collection Data for both studies is collected from existing digital and manual prehospital care reports (digital models: Cosmic, Ortivus, Paratus, TakeCare and manually written prehospital care reports (PCR)). The participating prehospital care providers will be the regional council of Uppsala, Jämtland/Härjedalen and Dalarna and the county council of Värmland. Data retrieved is scene location, time from dispatch to arrival to the patient on scene, time from dispatch to prehospital assessment/treatment, time from dispatch to patient arrival at the receiving health care facility, location of the receiving facility, type of condition, vital signs in the prehospital setting, treatment and survey of the patient. Searching and extracting data will be done using protocols where the study outcomes are documented as intended to answer the purpose of the study. Exported data from all patient record systems are reviewed for quality.

The IBM SPSS Version 25 Statistics Program will be used. The collected data will be processed with descriptive and comparative analyses as with regression models to evaluate the significance of variables for medical complications and mortality.

Exposed group: Patients suffering TBI or acute MI and has been treated by HEMS crews dispatched by an emergency dispatch centre re in all the counties.

Reference group: Patients suffering TBI or acute MI and has been treated by GEMS dispatched by an emergency dispatch centre.

Possible confounders Several confounders are yet unknown but this will be probably clarified by study I.

Outcome The primary outcome is mortality, and will be controlled with measure of time from dispatch to assessment and treatment to patient arrival at the receiving medical facility The secondary outcomes are comorbidity (diabetes), medical complications (Infection, haemorrhage) and 30-day mortality. Independent variables: HEMS vs GEMS and these groups will be controlled for age, sex and possible other variables that will be examined for their impact on regression models

Description of the groups (Study II) Exposed group: Patients suffering TBI or acute MI and has been treated by helicopter emergency medical service crews dispatched by an emergency dispatch center.

Reference group: Patients suffering TBI or acute MI and has been treated by ground emergency medical service care providers dispatched by an emergency dispatch center.

Power calculation: A power calculation is made in study II where comparative analysis are to be used.

Description of project logistics Information on the aim of study I and its implementation will be provided to the staff at all HEMS bases and to all ambulance stations in the regions participating in the study. The information will be given primarily to the medical director and the director of operations responsible for HEMS operations and GEMS. Data extract from digital PCR systems will be carried out by the operation managers. Manual data collection from HEMS is carried out by the collaborator of the study on the basis of approval from the director of operations. Data extracts of patients considered to suffer an TBI or acute MI are performed based on the outcomes of the study. Data extracts are handed over unidentified to researcher and is provided in a pre-defined folder on the computer of the responsible researcher through the server of the region where the computer is encrypted.

Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03940443
Study groupRoleWhat they receive
Ground Emergency Medical ServicesPatients suffering TBI or acute MI and has been treated by GEMS dispatched by an emergency dispatch centre.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    The primary outcome is mortality, and will be controlled with measure of time from dispatch to assessment and treatment to patient arrival at the receiving medical facility. Timeframe from inclusion until death, up to 30 days. The outcome will be reported in numbers by proportion of participants and with tables in percentage.

    Measured: January 1st, 2017 to December 31st, 2018

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2019
  2. Study start3 Sep 2019
  3. Primary completion1 Jun 2021 (estimated)
  4. Study completion1 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03940443
Sponsor's protocol ID
HDa 5.2.2-2017/745
Status last verified
Feb 2021
First submitted
13 Mar 2019
Last updated
16 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Krafft T, Garcia Castrillo-Riesgo L, Edwards S, Fischer M, Overton J, Robertson-Steel I, Konig A. European Emergency Data Project (EED Project): EMS data-based health surveillance system. Eur J Public Health. 2003 Sep;13(3 Suppl):85-90. doi: 10.1093/eurpub/13.suppl_1.85.

    PubMed 14533755
  • Georgette E, Simon B, James R. HEMS dispatch: A systematic review. Trauma. 2018;20(1):8.

  • Suserud B-O, Lundberg L. Prehospital akutsjukvård. 2 ed. Stockholm: Liber; 2016. 560 p.

  • Delgado MK, Staudenmayer KL, Wang NE, Spain DA, Weir S, Owens DK, Goldhaber-Fiebert JD. Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States. Ann Emerg Med. 2013 Oct;62(4):351-364.e19. doi: 10.1016/j.annemergmed.2013.02.025. Epub 2013 Apr 9.

    PubMed 23582619
  • Andruszkow H, Hildebrand F, Lefering R, Pape HC, Hoffmann R, Schweigkofler U. Ten years of helicopter emergency medical services in Germany: do we still need the helicopter rescue in multiple traumatised patients? Injury. 2014 Oct;45 Suppl 3:S53-8. doi: 10.1016/j.injury.2014.08.018.

    PubMed 25284235
  • Andruszkow H, Schweigkofler U, Lefering R, Frey M, Horst K, Pfeifer R, Beckers SK, Pape HC, Hildebrand F. Impact of Helicopter Emergency Medical Service in Traumatized Patients: Which Patient Benefits Most? PLoS One. 2016 Jan 15;11(1):e0146897. doi: 10.1371/journal.pone.0146897. eCollection 2016.

    PubMed 26771462
  • Blankenship JC, Haldis TA, Wood GC, Skelding KA, Scott T, Menapace FJ. Rapid triage and transport of patients with ST-elevation myocardial infarction for percutaneous coronary intervention in a rural health system. Am J Cardiol. 2007 Sep 15;100(6):944-8. doi: 10.1016/j.amjcard.2007.04.031. Epub 2007 Jul 2.

    PubMed 17826374
  • Hesselfeldt R, Pedersen F, Steinmetz J, Vestergaard L, Simonsen L, Jorgensen E, Clemmensen P, Rasmussen LS. Implementation of a physician-staffed helicopter: impact on time to primary PCI. EuroIntervention. 2013 Aug 22;9(4):477-83. doi: 10.4244/EIJV9I4A77.

    PubMed 23965353
  • Pathan SA, Soulek J, Qureshi I, Werman H, Reimer A, Brunko MW, et al. Helicopter EMS and rapid transport for ST-elevation myocardial infarction: The HEARTS study. Journal of Emergency Medicine, Trauma and Acute Care. 2017;2017(1):8.

  • Thomas SH, Blumen I. Helicopter Emergency Medical Services Literature 2014 to 2016: Lessons and Perspectives, Part 1-Helicopter Transport for Trauma. Air Med J. 2018 Jan-Feb;37(1):54-63. doi: 10.1016/j.amj.2017.10.006. Epub 2017 Dec 6. No abstract available.

    PubMed 29332779
  • Thomas SH, Blumen I. Helicopter Emergency Medical Services Literature 2014 to 2016: Lessons and Perspectives, Part 2-Nontrauma Transports and General Issues. Air Med J. 2018 Mar-Apr;37(2):126-130. doi: 10.1016/j.amj.2017.10.005. Epub 2017 Dec 6. No abstract available.

    PubMed 29478578
  • Ringburg AN, de Ronde G, Thomas SH, van Lieshout EM, Patka P, Schipper IB. Validity of helicopter emergency medical services dispatch criteria for traumatic injuries: a systematic review. Prehosp Emerg Care. 2009 Jan-Mar;13(1):28-36. doi: 10.1080/10903120802472012.

    PubMed 19145521
  • Fevang E, Lockey D, Thompson J, Lossius HM; Torpo Research Collaboration. The top five research priorities in physician-provided pre-hospital critical care: a consensus report from a European research collaboration. Scand J Trauma Resusc Emerg Med. 2011 Oct 13;19:57. doi: 10.1186/1757-7241-19-57.

    PubMed 21996444
  • Galvagno SM Jr, Sikorski R, Hirshon JM, Floccare D, Stephens C, Beecher D, Thomas S. Helicopter emergency medical services for adults with major trauma. Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009228. doi: 10.1002/14651858.CD009228.pub3.

    PubMed 26671262
  • Scholten AC, Haagsma JA, Panneman MJ, van Beeck EF, Polinder S. Traumatic brain injury in the Netherlands: incidence, costs and disability-adjusted life years. PLoS One. 2014 Oct 24;9(10):e110905. doi: 10.1371/journal.pone.0110905. eCollection 2014.

    PubMed 25343447

Questions about this trial

What is this clinical trial studying?

An observational study of Ambulances and Traumatic Brain Injury, run by Dalarna County Council, Sweden at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David Summermatter, RN (+46 72 249 55 40, david.summermatter@ltdalarna.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: January 1st, 2017 to December 31st, 2018). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03940443, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in